Health Condition 1: Q049- Congenital malformation of brain,unspecified
Conditions
Interventions
Intervention1: BHC9612CP Capsule Test product: Capsule dosage form
Three times daily after meal
Control Intervention1: Placebo: Capsule dosage form Three times daily after meal
Sponsors
Botanic Healthcare Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Both male and female subjects aged between 40-75 years with a complaint of memory impairment for at least one year without any major cognitive deficit. 2.Subjects who are willing to sign ICF
Exclusion criteria
Exclusion criteria: 1.Subjects with Psychiatric disorders 2.Subjects with alcohol consumption 3.Subjects with any organ system infection in past 30 days 4.Subjects with severe cognitive problems like dementia, function disability, post 5.vascular cerebral symptoms or with any neurological problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the efficacy and safety of Ashwagandha in subjects with cognitive impairmentTimepoint: Day 0 Day 28 and Day 56 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Adverse events (AEs), frequency and severity. 2.Number of subjects who discontinue study due to adverse events 3.Changes in vital parameters and laboratory investigations Timepoint: Day 0 Day 28 and Day 56 | — |
Countries
India
Contacts
Public ContactDrShubarani
Bangalore Clinical Services
Outcome results
None listed